Adenine nucleotide analogue

ID: ALA3350535

Chembl Id: CHEMBL3350535

PubChem CID: 118718991

Max Phase: Preclinical

Molecular Formula: C16H27IN7O14P3

Molecular Weight: 761.25

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1ncnc2c1nc(NCCCCNC(=O)CI)n2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O

Standard InChI:  InChI=1S/C16H27IN7O14P3/c17-5-9(25)19-3-1-2-4-20-16-23-10-13(18)21-7-22-14(10)24(16)15-12(27)11(26)8(36-15)6-35-40(31,32)38-41(33,34)37-39(28,29)30/h7-8,11-12,15,26-27H,1-6H2,(H,19,25)(H,20,23)(H,31,32)(H,33,34)(H2,18,21,22)(H2,28,29,30)/t8-,11-,12-,15-/m1/s1

Standard InChI Key:  RYULCWWGYGDIKM-PMXXHBEXSA-N

Alternative Forms

  1. Parent:

    ALA3350535

    ---

Associated Targets(non-human)

Hk1 Hexokinase type I (47 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hk2 Hexokinase type II (49 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hk3 Hexokinase type III (47 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 761.25Molecular Weight (Monoisotopic): 760.9874AlogP: -0.89#Rotatable Bonds: 15
Polar Surface Area: 320.26Molecular Species: ACIDHBA: 16HBD: 9
#RO5 Violations: 3HBA (Lipinski): 21HBD (Lipinski): 10#RO5 Violations (Lipinski): 3
CX Acidic pKa: 0.90CX Basic pKa: 4.48CX LogP: -4.61CX LogD: -9.77
Aromatic Rings: 2Heavy Atoms: 41QED Weighted: 0.05Np Likeness Score: 0.56

References

1. Hampton A, Patel AD, Chawla RR, Kappler F, Hai TT..  (1982)  Use of adenine nucleotide derivatives to assess the potential of exo-active-site-directed reagents as species- or isozyme-specific enzyme inactivators. 5. Interactions of adenosine 5'-triphosphate derivatives with rat pyruvate kinases, Escherichia coli thymidine kinase, and yeast and rat hexokinases.,  25  (4): [PMID:7040662] [10.1021/jm00346a011]

Source